Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Irregular Shift Work Ups Risk for Type 2 Diabetes

Published: Thu, 22 Feb 2018 16:48:28 EST
People who work rotating shifts, especially those who work a lot of nights, are more likely to have type 2 diabetes than those who only work during the day or those on permanent nights.
Medscape Medical News

Fewer HF Readmissions After Cardiology vs Hospitalist Care

Published: Thu, 22 Feb 2018 16:12:41 EST
Readmissions at 30 days were up for discharged patients with heart failure cared for on the general medicine service. A possible fix: more opportunities for hospitalists to learn strategies for optimal heart failure care.
Medscape Medical News

Allergy Drug May Reduce Relapse in Neuromyelitis Optica

Published: Thu, 22 Feb 2018 15:50:03 EST
The pilot study, which showed an effect of allergy drug cetirizine, suggests a key role of eosinophils in the pathogenesis of NMO, researchers say.
Medscape Medical News

CDC Tackles Traumatic Brain Injury in Children

Published: Thu, 22 Feb 2018 15:06:06 EST
CDC report finds gaps in care and outlines opportunities for action on TBI in childhood.
Medscape Medical News
Displaying results 13-16 (of 20)
 1 - 2 - 3 - 4 - 5 


AbbVie doubles down on tau with Voyager Alzheimer's deal

Published: Tue, 20 Feb 2018 13:19:03 +0000
AbbVie has teamed up with Voyager Therapeutics on a tau protein-targeting program, paying $69 million upfront for an option on the Alzheimer’s disease candidate.

Takeda rides the neuro R&D Wave with latest biotech pact

Published: Tue, 20 Feb 2018 12:52:01 +0000
Perennial biotech dealmaker Takeda is at it again, striking a new pact with Wave Life Sciences with a focus on a series of difficult-to-treat neurological disorders.

Lilly scraps rheumatoid arthritis trial after interim review

Published: Tue, 20 Feb 2018 08:38:28 +0000
Eli Lilly has halted a phase 2 rheumatoid arthritis trial after getting a midstudy glimpse at the data. The setback leaves Lilly and partner Hanmi Pharmaceutical to weigh whether it is worth moving the Bruton's TKI forward in other indications.

Apricus craters as FDA rejects erectile dysfunction cream again

Published: Fri, 16 Feb 2018 13:39:42 +0000
The FDA has issued a complete response letter for Apricus’ topical erectile dysfunction drug Vitaros for the second time, sparking a massive after-hours slump in its share price.
Displaying results 13-16 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy